Placement Announced
NeuroScientific Biopharmaceuticals placement
A$3.5m raised
Announced 16 Apr 2025 · ASX: NSB · A$0.035 cash per share
Advisers
NeuroScientific Biopharmaceuticals
Issuer
Not disclosed
Lead managers
- Lead manager
- Issuer
- NeuroScientific Biopharmaceuticals
- Sector
- Biotech and pharmaceuticals
Similar deals
- Recce Pharmaceuticals placement Jun 2026 · A$4m · Biotech and pharmaceuticals
- Bioxyne placement Mar 2025 · A$3m · Biotech and pharmaceuticals
- TrivarX placement Oct 2025 · A$4.2m · Biotech and pharmaceuticals
- Neurizon Therapeutics placement Nov 2026 · A$4.3m · Biotech and pharmaceuticals
- Chimeric Therapeutics placement Dec 2025 · A$4.4m · Biotech and pharmaceuticals
Sources
- 16 Apr 2025 NeuroScientific to Acquire Leading Stem Cell Technology ASX